| PERIOD ENDING | 31-Jul-09 | 31-Jul-08 | 31-Oct-07 | | Total Revenue | 7,827 | 6,148 | 8,177 | | Cost of Revenue | 795 | 619 | 750 | | | Gross Profit | 7,032 | 5,529 | 7,426 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 167 | 135 | 237 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 6,865 | 5,394 | 7,189 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (9,099) | (6,017) | (3,210) | | Earnings Before Interest And Taxes | 6,865 | 5,394 | 7,189 | | Interest Expense | 92 | 31 |
-
| | Income Before Tax | 6,773 | 5,363 | 7,189 | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,326) | (654) | 3,979 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (2,326) | (654) | 3,979 | | Preferred Stock And Other Adjustments | (928) | (1,449) | (2,093) | | | Net Income Applicable To Common Shares | ($3,254) | ($2,103) | $1,886 |
|
0.51% Nasdaq 
Income Statement
